4Lucas S, De Smet C, Arden KC, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis [ J ]. Cancer Res, 1998, 58 (4) :743-752.
5Kawakami Y, Dang N, Wang X, et al. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma[J]. J Immunother,2000,23 ( 1 ) : 17-27.
6Mou DC, Cai SL, Peng JR, et al. Evaluation of MAGE-1 and MAGE-3 as tumor-specific markers to detect blood dissemination of hepatocellular carcinoma cells [ J ]. Br J Cancer, 2002, 86 ( 1 ) : 110-116.
7Risin D, Kleinerman ES, Umezu Y, et al. Impairment of lymphocyte locomotion in the tumor mi t and the effect of systemic immunotherapy with liposome encapsulated muramyl tripeptide phosphatidylethanolamine [ J ]. Cancer Immunol Immunother, 1995,40 ( 1 ):57-64.
8Dillman R, Sehiltz P, DePriest C, et al. Tumor-infiltrating lymphocytes and interleukin-2 : dose and schedules of administration in the treatment of metastatic cancer [ J ]. Cancer Biother Radiopharm, 2004,19(6) :730-737.
9Cohen CA, Shea AA, Heffron CL, et al. The parity-associated mi-croenvironmental niche in the omental fat band is refractory to ovar-ian cancer metastasis [ J ]. Cancer Prev Res ( Phila) , 2013,6(11):1182-1193.
10Rosenberg SA, Spiess P, Lafreniere R. A new approach to the a-doptive immunotherapy of cancer with tumor-infiltrating lympho-cytes [J]. Science, 1986,233(4770) :1318-1321.
